Literature DB >> 28281170

Factors Related to Upper Gastrointestinal Symptom Generation in 2275 Helicobacter pylori Seroprevalent Adults.

Sang Pyo Lee1, Sun-Young Lee2, Jeong Hwan Kim1, In-Kyung Sung1, Hyung Seok Park1, Chan Sup Shim1.   

Abstract

BACKGROUND AND AIM: Upper gastrointestinal (UGI) symptoms are common; however, the role of Helicobacter pylori and gastric corpus atrophy in the generation of these symptoms is controversial. The aim of this study was to determine the risk factors for UGI symptoms in adults in an endemic area of H. pylori infection.
METHODS: Korean adults who completed questionnaires on the day of serum anti-H. pylori IgG and pepsinogen (PG) assays before UGI endoscopy were included. Gastric corpus atrophy was based on the criteria of a serum PG I/II ratio <3.0 and a PG I <70 ng/ml.
RESULTS: Of the 2275 included subjects, 723 (31.8%) had at least one UGI symptom. A total of 374 (16.4%) subjects had multiple symptoms without significant correlations between the symptoms (λ < 0.2). The H. pylori serology assay was positive in 1382 (60.7%) subjects, and gastric corpus atrophy was present in 291 (12.8%). Neither H. pylori seropositivity (p = 0.077) nor gastric corpus atrophy (p = 0.138) was related to the presence of UGI symptoms. Female gender and smoking were independent risk factors for heartburn and upper abdominal pain (all p < 0.001). Furthermore, female gender was the only independent risk factor for multiple UGI symptoms (p < 0.001), globus sensation (p < 0.001), early satiety (p < 0.001), epigastric soreness (p = 0.001), and chest discomfort (p = 0.003).
CONCLUSIONS: In an H. pylori seroprevalent population, female gender is the most common risk factor followed by smoking for UGI symptom generation. Neither H. pylori seropositivity nor gastric corpus atrophy is an independent risk factor for UGI symptom generation.

Entities:  

Keywords:  Female; Gastric atrophy; Helicobacter pylori; Upper gastrointestinal symptom

Mesh:

Substances:

Year:  2017        PMID: 28281170     DOI: 10.1007/s10620-017-4529-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study.

Authors:  H Miwa; S Hirai; A Nagahara; T Murai; T Nishira; S Kikuchi; Y Takei; S Watanabe; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2000-03       Impact factor: 8.171

2.  Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients.

Authors:  Zhu Wei; Liu Ying; Guo Wen; Zhang Mengnan; Zhang Yali
Journal:  Helicobacter       Date:  2014-02-07       Impact factor: 5.753

3.  Gastric hypochlorhydria is associated with an exacerbation of dyspeptic symptoms in female patients.

Authors:  Wataru Iwai; Yasuhiko Abe; Katsunori Iijima; Tomoyuki Koike; Kaname Uno; Naoki Asano; Akira Imatani; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2012-07-25       Impact factor: 7.527

4.  Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.

Authors:  Shigeto Mizuno; Ikuya Miki; Tsukasa Ishida; Masaru Yoshida; Mitsuko Onoyama; Takeshi Azuma; Yasuki Habu; Hideto Inokuchi; Kotaro Ozasa; Kazumasa Miki; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2010-03-04       Impact factor: 3.199

Review 5.  Mechanisms of disease: nicotine--a review of its actions in the context of gastrointestinal disease.

Authors:  Gareth A O Thomas; John Rhodes; John R Ingram
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-11

6.  Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis.

Authors:  Y Liu; G D C Vosmaer; G N J Tytgat; S-D Xiao; F J W Ten Kate
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

7.  Dyspeptic symptoms in middle-aged to old adults: the role of Helicobacter pylori infection, and various demographic and lifestyle factors.

Authors:  G Bode; H Brenner; G Adler; D Rothenbacher
Journal:  J Intern Med       Date:  2002-07       Impact factor: 8.989

8.  Association of endoscopic appearances with dyspeptic symptoms.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Masaaki Okubo; Daisuke Yoshioka; Fangyu Wang; Hiroshi Nakano; Ichiro Hirata
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

Review 9.  Review article: Helicobacter pylori and reflux disease.

Authors:  P Sharma; N Vakil
Journal:  Aliment Pharmacol Ther       Date:  2003-02       Impact factor: 8.171

Review 10.  Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.

Authors:  Sun-Young Lee
Journal:  Korean J Intern Med       Date:  2016-09-01       Impact factor: 2.884

View more
  4 in total

1.  Helicobacter pylori-Associated Upper Gastrointestinal Symptoms: FD or HpD?

Authors:  Hidekazu Suzuki
Journal:  Dig Dis Sci       Date:  2017-06       Impact factor: 3.199

Review 2.  Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift.

Authors:  Hye-Kyung Jung; Nicholas J Talley
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

3.  Correlations of the Gastric and Duodenal Microbiota with Histological, Endoscopic, and Symptomatic Gastritis.

Authors:  Hye Seung Han; Sun-Young Lee; Seo Young Oh; Hee Won Moon; Hyunseok Cho; Ji-Hoon Kim
Journal:  J Clin Med       Date:  2019-03-05       Impact factor: 4.241

4.  Higher frequency of upper gastrointestinal symptoms in healthy young Japanese females compared to males and older generations.

Authors:  Kojiro Kawachi; Yasuhisa Sakata; Megumi Hara; Eri Takeshita; Hiroharu Kawakubo; Daisuke Yamaguchi; Norihiro Okamoto; Ryo Shimoda; Ryuichi Iwakiri; Nanae Tsuruoka; Motoyasu Kusano; Kazuma Fujimoto
Journal:  Esophagus       Date:  2017-12-19       Impact factor: 4.230

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.